Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Condensing Agent > Eptifibatide for Sale > Hot sale Eptifibatide raw powder match with US,EU, cGMP standard
Hot sale Eptifibatide raw powder match with US,EU, cGMP standard buy - large image1
Hot sale Eptifibatide raw powder match with US,EU, cGMP standard buy - image1
Hot sale Eptifibatide raw powder match with US,EU, cGMP standard buy - image2
Hot sale Eptifibatide raw powder match with US,EU, cGMP standard buy - image3
Hot sale Eptifibatide raw powder match with US,EU, cGMP standard buy - image4
Hot sale Eptifibatide raw powder match with US,EU, cGMP standard buy - image5
Hot sale Eptifibatide raw powder match with US,EU, cGMP standard buy - image6

Hot sale Eptifibatide raw powder match with US,EU, cGMP standard

TDS 2 Inquiries

Unit Price: Get Latest Price
CAS No.:

188627-80-7

Grade:

Pharmaceutical Grade

Content:

99%

Port:

hangzhou

Brand:

thinheal

Packaging:

1g/bag

Price valid (until):

2025-01-10

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Linaclotide,Semaglutide,Plecanatide,Retatrutide,Eptifibatide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    Eptifibatide CAS 188627-80-7


    Product Name  Eptifibatide
    CAS.No 188627-80-7
    Synonyms Eptifibatide acetate salt;Eptifibatide,MPA-HAR-Gly-Asp-Trp-Pro-Cys-NH2,MPAHARGDWPC-NH2, >99%;MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;MPA-HAR-GLY-ASP-TRP-PRO-CYS-NH2(DISULFIDE BRIDGE, MPA1-CYS6);Intrifiban
    Purity 99%
    Application Eptifibatide is a cyclical heptapeptide with anticoagulant activity. Eptifibatide selectively and reversibly binds to and blocks the platelet glycoprotein IIb/IIIa receptor. This prevents the binding of fibrinogen, von Willebrand factor, and other adhesive ligands and leads to an inhibition of platelet aggregation and prevents thrombus development. It is an efficient peptide drug to reduce the risk of cardiac ischemic events, however has a short half-life. Therefore, antithrombotic agents like eptifibatide are required to become improved with a protected and targeted delivery system such as using nano-liposomes to the site of thrombus.



    Eptifibatide CAS 188627-80-7 Picture 


    Shop Linacllotide-Detailed Image 1


      About us   


    Hangzhou ThinHeal Pharma-Tech Co., Ltd. is headquartered in Hangzhou, P.R. China. ThinHeal focuses on peptide products and our team has extensive experience in drug research and development with launched products in domestic markets and United States, Europe and Japan.

    ThinHeal is devoted to building an international peptide delivery system to provide customers one-stop solutions for peptide products. We have established an effective and scientific quality assurance system to meet the international application requirements; a 2,000 square meter R&D center in Hangzhou equipped with high performance liquid chromatography, mass spectrometry system, gas chromatography, freeze dryer, etc.; and seasoned employees that ensure the progress of R & D projects and products.

    Based on the above, we can provide customers all products about peptide: new peptide products, generics, full sets of peptide impurities, consistency evaluation technology development.

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 2 Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 3


      Equipment Display


    Synthesis Reactor

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 4

    Cleavage Reactor

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 5

    Preparative HPLC

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 6

    Lyophilizer

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 7


      Lab  


    HPLCs

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 8 Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 9

    LC-MS-MS & GCs

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 10


      Service 


    To meet the needs of customers for new drug development, impurity research, and quality improvement, the company provides customized services for high-end peptide products, including process development and product customization of drug peptide impurities, intermediates, peptide fragments, and peptide new drugs. Customized services can be upgraded according to customer product development needs, including a complete set of impurity preparation that meets registration requirements, GMP level peptide drug declaration, and production services.

    Certificates

    Basic Info
    Product Name:

    Eptifibatide

    Other Name:

    MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;Intrifiban;N6-(AMinoiMinoMethyl)-N2-(3-Mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-L-cysteinaMide Cyclic (16)-Disulfide;3-Mercaptopropionyl-HoMoarg-Gly-Asp-Trp-Pro-Cys-NH2

    CAS No.:

    188627-80-7

    Molecular Formula:

    C35H49N11O9S2

    InChIKeys:

    CZKPOZZJODAYPZ-UHFFFAOYSA-N

    Molecular Weight:

    831.96

    Exact Mass:

    831.315613

    EC Number:

    1312995-182-4

    DSSTox ID:

    DTXSID7046673

    Categories:

    Condensing Agent

    Characteristics
    PSA:

    377 Ų

    XLogP3:

    log Kow = -4.33 (est)

    Density:

    1.6±0.1 g/cm3

    Refractive Index:

    1.735

    Water Solubility:

    In water, 1108 mg/L at 25 °C (est)

    Storage Conditions:

    Eptifibatide should be refrigerated at between 2-8 °C and protected from light until administration.|Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature -20 °C. Store with desiccant. /Eptifibatide acetate/

    Vapor Pressure:

    1.78X10-40 mm Hg at 25 °C (est)

    Henrys Law Constant:

    Henry's Law constant = 9.88X10-34 atm-cu m/mol at 25 °C (est)

    Experimental Properties:

    Hydroxyl radical reaction rate constant = 6.79X10-10 cu cm/molec-sec at 25 °C (est)

    Hazard Identification

    Classification of the substance or mixture

    Specific target organ toxicity – single exposure, Category 1

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H370 Causes damage to organs

    Precautionary statement(s)
    Prevention

    P260 Do not breathe dust/fume/gas/mist/vapours/spray.

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P308+P316 IF exposed or concerned: Get emergency medical help immediately.

    P321 Specific treatment (see ... on this label).

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Linaclotide,Semaglutide,Plecanatide,Retatrutide,Eptifibatide

    Location:

    8th Floor, Building 2, Heji R&D Center, Xiasha Street, Qiantang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,L/C,100% TT in advance

    Average lead Time:

    20

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    201-300

    Year of Establishment:

    2019

    Hangzhou ThinHeal Co., Ltd.


     Misson 


    To make our company be the 

    1.The One-stop CRDMO Partner of Peptide Drugs

    2.The Cutting-edge Peptide Technology Innovator

    3.The Most Cost-effective Peptide Manufacturer

    4. The High Quality and Large Scale cGMP Peptide Supplier


    Introduction


    Hangzhou ThinHeal Co., Ltd.  is headquartered in Hangzhou, P.R. China. ThinHeal focuses on peptide products and our team has extensive experience in drug research and development with launched products in domestic markets and United States, Europe and Japan.

    ThinHeal is devoted to building an international peptide delivery system to provide customers one-stop solutions for peptide products. We have established an effective and scientific quality assurance system to meet the international application requirements; a 2,000 square meter R&D center in Hangzhou equipped with high performance liquid chromatography, mass spectrometry system, gas chromatography, freeze dryer, etc.; and seasoned employees that ensure the progress of R & D projects and products.

    Based on the above, we can provide customers all products about peptide: new peptide products, generics, full sets of peptide impurities, consistency evaluation technology development.


    Key andvantage  


    1.Recognized quality management system Based on Chinese GMP, 21CFR part 210, 211, EU cGMP Volume 4 and ICH Guidelines, ThinHeal has established a quality management system encompassing the product lifecycle, providing comprehensive quality assurance for the products.

    2. Effective project managements With abundant experience of multiple projects managements, ThinHeal can ensure the smooth and effective implementation of the projects per customer’s requirements.

    3. cGMP experiences With extensive cGMP management experiences, ThinHeal can undertake the product transfer, process validation, and commercial manufacturing according to the cGMP requirements of different countries (including China, the United States, the European Union, and Japan).

    4. Cost effective managements,Cost is always considered by ThinHeal during the peptide synthesis route selection, purification process optimization and the quality control. ThinHeal helps our customers improve the product quality with cost effective and efficient solutions.

    5. Platform for process development 

    API: up to 40 amino acids synthesis experience, including but not limited to the synthesis of linear peptide/cyclic peptide/multiple disulfide bonds; solid phase/liquid phase peptide synthesis & assembly coupling; peptide modification & Multi cyclic peptide synthesis. 

    Finished Products: including injection, oral controlled release preparation, long-term peptide injection process development and quality control, scale-up and stability study experience.

    6. More than 20 years experience for regulatory application and registration in both dosmetic and overseas.

  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Uzbekistan

    Eptifibatide

    60 G Dec 10, 2023
    India

    Eptifibatide

    10 G May 13, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.